Keros Therapeutics, Inc. — All Filings
481 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS EX
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4/A | — | 0002081460-26-000007 | Mar 27, 2026 | Feb 24, 2026 |
| SCHEDULE 13G/A | — | 0000102909-26-001617 | Mar 27, 2026 | — |
| 4 | — | 0001866219-26-000005 | Mar 11, 2026 | Mar 9, 2026 |
| 3 | — | 0001866219-26-000003 | Mar 11, 2026 | Mar 9, 2026 |
| 4 | — | 0001221590-26-000002 | Mar 11, 2026 | Mar 9, 2026 |
| 8-K | 8-K | 0001664710-26-000024 | Mar 9, 2026 | — |
| 8-K | 8-K | 0001664710-26-000021 | Mar 4, 2026 | — |
| S-8 | S-8 | 0001664710-26-000020 | Mar 4, 2026 | — |
| 10-K | 10-K | 0001664710-26-000018 | Mar 4, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001664710-26-000017 | Mar 4, 2026 | — |
| 4 | — | 0001732369-26-000008 | Feb 26, 2026 | Feb 24, 2026 |
| 4 | — | 0001682068-26-000005 | Feb 26, 2026 | Feb 24, 2026 |
| 4 | — | 0002081460-26-000004 | Feb 26, 2026 | Jan 5, 2026 |
| 4 | — | 0002081359-26-000005 | Feb 26, 2026 | Feb 24, 2026 |
| 8-K | 8-K | 0001664710-26-000008 | Feb 26, 2026 | Feb 20, 2026 |
| 4 | — | 0001732369-26-000004 | Feb 20, 2026 | Feb 19, 2026 |
| 4 | — | 0002081359-26-000002 | Feb 20, 2026 | Feb 18, 2026 |
| 4 | — | 0002081460-26-000002 | Feb 20, 2026 | Feb 18, 2026 |
| 4 | — | 0001682068-26-000003 | Feb 20, 2026 | Feb 18, 2026 |
| 8-K | 8-K | 0001664710-26-000005 | Feb 18, 2026 | — |
| SCHEDULE 13G/A | — | 0000905148-26-000905 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001013594-26-000256 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001214659-26-002021 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001104659-26-016389 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0000102909-26-000162 | Jan 30, 2026 | — |
| 8-K | 8-K | 0001664710-26-000003 | Jan 9, 2026 | — |
| 4 | — | 0001732369-26-000002 | Jan 9, 2026 | Jan 7, 2026 |
| 4 | — | 0000947871-25-001085 | Dec 18, 2025 | Nov 21, 2025 |
| 4 | — | 0000947871-25-001084 | Dec 18, 2025 | Nov 21, 2025 |
| 4 | — | 0001808365-25-000005 | Dec 18, 2025 | Nov 21, 2025 |
| SC TO-I/A | SC TO-I/A | 0001104659-25-114608 | Nov 20, 2025 | — |
| SC TO-I/A | SC TO-I/A | 0001104659-25-113880 | Nov 19, 2025 | — |
| SCHEDULE 13G | — | 0000905148-25-004126 | Nov 18, 2025 | — |
| 10-Q | 10-Q | 0001664710-25-000089 | Nov 5, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001664710-25-000086 | Nov 5, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-102591 | Oct 27, 2025 | — |
| SCHEDULE 13G | — | 0001214659-25-015219 | Oct 22, 2025 | — |
| SC TO-I | SC TO-I | 0001104659-25-100554 | Oct 20, 2025 | — |
| 4 | OWNERSHIP DOCUMENT | 0000921895-25-002765 | Oct 17, 2025 | Oct 15, 2025 |
| SCHEDULE 13D/A | — | 0000921895-25-002751 | Oct 16, 2025 | — |
| 4 | — | 0000902664-25-004411 | Oct 15, 2025 | — |
| SCHEDULE 13D/A | — | 0000902664-25-004410 | Oct 15, 2025 | — |
| SC TO-C | SC TO-C | 0001104659-25-099513 | Oct 15, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-099512 | Oct 15, 2025 | — |
| 144 | — | 0001969223-25-000767 | Sep 12, 2025 | — |
| 8-K | 8-K | 0001664710-25-000081 | Sep 8, 2025 | — |
| 4 | — | 0001415889-25-023791 | Sep 5, 2025 | Sep 3, 2025 |
| 8-K | 8-K | 0001664710-25-000078 | Aug 28, 2025 | — |
| SCHEDULE 13D/A | — | 0000902664-25-003804 | Aug 21, 2025 | — |
| 8-K | 8-K | 0001664710-25-000073 | Aug 20, 2025 | — |